| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.0036 | 1 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.0084 | 1 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00095 | 1 |